IQVIA Holdings | IQV - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Accenture USD 15.55B 10.37M 2025-12
Agilent USD 1.44B 9M 2026-03
Bruker USD 813.2M 87.7M 2026-03
Cardinal Health USD -2.83B 52M 2026-03
Celltrion KRW 140.68B 584.31B 2025-12
Charles River Laboratories USD 875.93M 42.48M 2026-03
Cigna USD 42.21B 497.12M 2026-03
Cognizant Technology Solutions USD 15.07B 10.59B 2026-03
Computer Programs Systems USD 207.2M 119.28M 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
CVS Health USD 95.75B 7.84B 2026-03
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 1.32B 895M 2026-03
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 20.17B 1.85B 2026-03
Elevance Health USD 43.9B 5.26B 2026-03
Humana USD 37.89B 4.57B 2026-03
IBM USD 32.97B 17.54B 2026-03
Illumina USD 852M 51M 2026-03
Infosys INR 370.7B 366.69B 2025-12
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.13B 6.3M 2026-03
Malin Corporation EUR 1.1M 400K 2024-12
McKesson USD 94.46B 10.04B 2026-03
Mettler Toledo International USD 713.2M 64.61M 2026-03
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pharma Mar EUR 42.28M 4.59M 2026-03
Publicis EUR 7.53B 244M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Tilray USD 237.52M 17.34M 2025-09
UnitedHealth USD 102.68B 7.27B 2026-03
Veeva Systems USD 590.07M 19.69M 2025-12
Veradigm USD 188M 61.08M 2022-12
Waters USD 1.12B 457.15M 2026-03
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03